Synchrony Financial

The forensic screens give a reassuring but limited picture, and they measure only part of what matters for a credit card lender. The Beneish M-Score is -2.723, below the -1.78 threshold, and its label is not in the elevated manipulation-risk zone. That is a screening result, not proof that the reported figures are accurate. The Piotroski F-Score is 6 of 6 computable signals, meaning all six signals that could be calculated from the data came back favorable. The operating cash flow to net income ratio is 2.77, computed as $9.85 billion divided by $3.55 billion. A ratio above 1 means cash generated exceeded reported income. For a lender, a gap this wide is plausible when provisions for credit losses reduce reported income without using cash, so the CECL estimates described in the risk factors deserve a closer read. The Altman Z-Score and Fog Index were not on file, so this synthesis does not assess them. Other filing facts include the February 25, 2026 Fifteenth Supplemental Indenture, the 4.947% Fixed-to-Floating Rate Senior Notes due 2032, and two Rule 10b5-1 trading plans covering 51,258 and 10,000 shares. Long-term debt declined from $24 billion in 2018 to $15.18 billion in 2025. Legal matters are cross-referenced to Note 14, which is not included in the excerpt. Readers may want to look at Note 14, the CECL discussion in the MD&A, and the partner concentration risk factor in the full 10-K.

Catalyst.According to the 2025 10-K and the Q1 2026 10-Q, current activity centers on capital return. Net income was $3.55 billion in 2025 versus $3.5 billion in 2024, and revenue growth was 0.0% year over year. Operating cash flow was $9.85 billion in both years. In the first quarter of 2026, the company bought back 12,460,895 shares under publicly announced programs, leaving $287.0 million authorized under the 2025 plan. In April 2026, the board approved a new program of up to $6.5 billion with no expiration date, commencing in the second quarter. The excerpt provided does not describe a new product or segment driver, so readers may want to look at the full MD&A revenue discussion.

Hidden risk.The easiest tension to miss is between flat earnings and a large capital-return program. Net income rose only about 1.4% from 2024 to 2025, and operating cash flow was unchanged at $9.85 billion, yet the new authorization is up to $6.5 billion. Liabilities of $102.33 billion sit against equity of $16.77 billion at year-end 2025, a highly leveraged balance sheet that leaves a thin equity cushion. The risk-factor section names concentration in a small number of partners, reliance on models and CECL credit-loss estimates, and constraints on credit product pricing. The 10-Q states there were no material changes to those 10-K risk factors.